Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Encompass Health Co. stock logo
EHC
Encompass Health
$116.88
+0.4%
$103.77
$82.74
$118.27
$11.78B0.91684,517 shs687,735 shs
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
$14.34
-1.3%
$13.69
$6.62
$17.67
$1.23B1.26846,807 shs1.40 million shs
Reata Pharmaceuticals, Inc. stock logo
RETA
Reata Pharmaceuticals
$172.36
$171.30
$21.83
$172.46
$6.58B1.421.09 million shsN/A
Select Medical Holdings Co. stock logo
SEM
Select Medical
$15.27
+2.3%
$16.52
$14.03
$40.98
$1.96B1.4878,366 shs912,193 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Encompass Health Co. stock logo
EHC
Encompass Health
+0.36%+0.65%+14.35%+17.62%+35.07%
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
-1.98%+11.01%+7.41%-2.44%+74.46%
Reata Pharmaceuticals, Inc. stock logo
RETA
Reata Pharmaceuticals
0.00%0.00%0.00%0.00%0.00%
Select Medical Holdings Co. stock logo
SEM
Select Medical
+2.39%+3.18%-7.16%-19.59%-54.55%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Encompass Health Co. stock logo
EHC
Encompass Health
4.5967 of 5 stars
2.63.01.75.04.02.51.3
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
1.3305 of 5 stars
2.23.00.00.03.31.70.0
Reata Pharmaceuticals, Inc. stock logo
RETA
Reata Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Select Medical Holdings Co. stock logo
SEM
Select Medical
4.9985 of 5 stars
3.43.02.54.83.54.24.4
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Encompass Health Co. stock logo
EHC
Encompass Health
3.11
Buy$120.863.41% Upside
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
2.33
Hold$16.6716.22% Upside
Reata Pharmaceuticals, Inc. stock logo
RETA
Reata Pharmaceuticals
0.00
N/AN/AN/A
Select Medical Holdings Co. stock logo
SEM
Select Medical
2.80
Moderate Buy$26.0070.31% Upside

Current Analyst Ratings Breakdown

Latest SEM, EHC, MD, and RETA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/12/2025
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$18.50 ➝ $16.00
5/8/2025
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$19.00 ➝ $20.00
5/7/2025
Select Medical Holdings Co. stock logo
SEM
Select Medical
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$23.00 ➝ $19.00
4/28/2025
Encompass Health Co. stock logo
EHC
Encompass Health
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$117.00 ➝ $130.00
4/28/2025
Encompass Health Co. stock logo
EHC
Encompass Health
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$110.00 ➝ $125.00
4/28/2025
Encompass Health Co. stock logo
EHC
Encompass Health
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$116.00 ➝ $135.00
4/25/2025
Encompass Health Co. stock logo
EHC
Encompass Health
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$120.00 ➝ $122.00
4/25/2025
Encompass Health Co. stock logo
EHC
Encompass Health
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$118.00 ➝ $129.00
4/16/2025
Select Medical Holdings Co. stock logo
SEM
Select Medical
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$25.00
4/11/2025
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$18.00 ➝ $16.00
2/24/2025
Select Medical Holdings Co. stock logo
SEM
Select Medical
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$47.00 ➝ $23.00
(Data available from 5/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Encompass Health Co. stock logo
EHC
Encompass Health
$5.51B2.14$8.85 per share13.21$27.72 per share4.22
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
$1.98B0.62$2.92 per share4.91$8.91 per share1.61
Reata Pharmaceuticals, Inc. stock logo
RETA
Reata Pharmaceuticals
$23.48M280.05N/AN/A($1.79) per share-96.29
Select Medical Holdings Co. stock logo
SEM
Select Medical
$5.22B0.38$2.90 per share5.26$12.07 per share1.26
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Encompass Health Co. stock logo
EHC
Encompass Health
$455.70M$4.8426.2122.142.318.48%17.56%7.06%N/A
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
-$60.41M-$1.01N/A10.701.74-4.92%15.47%5.64%N/A
Reata Pharmaceuticals, Inc. stock logo
RETA
Reata Pharmaceuticals
-$311.90MN/A0.00N/AN/AN/A-922.50%-73.39%N/A
Select Medical Holdings Co. stock logo
SEM
Select Medical
$243.49M$1.349.2510.830.643.23%14.04%3.32%N/A

Latest SEM, EHC, MD, and RETA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2025Q1 2025
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
$0.25$0.33+$0.08$0.24$451.44 million$458.36 million
5/1/2025Q1 2025
Select Medical Holdings Co. stock logo
SEM
Select Medical
$0.45$0.44-$0.01$0.44$1.40 billion$1.35 billion
4/24/2025Q1 2025
Encompass Health Co. stock logo
EHC
Encompass Health
$1.19$1.37+$0.18$1.48$1.43 billion$1.46 billion
2/20/2025Q4 2024
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
$0.37$0.49+$0.12$0.36$486.22 million$502.36 million
2/20/2025Q4 2024
Select Medical Holdings Co. stock logo
SEM
Select Medical
$0.29$0.18-$0.11-$0.13$1.50 billion$1.31 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Encompass Health Co. stock logo
EHC
Encompass Health
$0.680.58%-17.02%14.05%2 Years
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
N/AN/AN/AN/AN/A
Reata Pharmaceuticals, Inc. stock logo
RETA
Reata Pharmaceuticals
N/AN/AN/AN/AN/A
Select Medical Holdings Co. stock logo
SEM
Select Medical
$0.251.64%+10.06%18.66%N/A

Latest SEM, EHC, MD, and RETA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/1/2025
Encompass Health Co. stock logo
EHC
Encompass Health
quarterly$0.170.59%7/1/20257/1/20257/15/2025
5/1/2025
Select Medical Holdings Co. stock logo
SEM
Select Medical
quarterly$0.06251.37%5/15/20255/15/20255/29/2025
2/20/2025
Encompass Health Co. stock logo
EHC
Encompass Health
quarterly$0.170.69%4/1/20254/1/20254/15/2025
2/13/2025
Select Medical Holdings Co. stock logo
SEM
Select Medical
quarterly$0.06252.8%3/3/20253/3/20253/13/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Encompass Health Co. stock logo
EHC
Encompass Health
0.84
1.05
1.04
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
0.81
1.60
1.42
Reata Pharmaceuticals, Inc. stock logo
RETA
Reata Pharmaceuticals
0.84
3.21
3.19
Select Medical Holdings Co. stock logo
SEM
Select Medical
1.37
1.13
1.13

Institutional Ownership

CompanyInstitutional Ownership
Encompass Health Co. stock logo
EHC
Encompass Health
97.25%
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
97.71%
Reata Pharmaceuticals, Inc. stock logo
RETA
Reata Pharmaceuticals
N/A
Select Medical Holdings Co. stock logo
SEM
Select Medical
89.48%

Insider Ownership

CompanyInsider Ownership
Encompass Health Co. stock logo
EHC
Encompass Health
2.00%
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
0.90%
Reata Pharmaceuticals, Inc. stock logo
RETA
Reata Pharmaceuticals
26.80%
Select Medical Holdings Co. stock logo
SEM
Select Medical
11.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Encompass Health Co. stock logo
EHC
Encompass Health
35,000100.80 million98.63 millionOptionable
Pediatrix Medical Group, Inc. stock logo
MD
Pediatrix Medical Group
7,85085.91 million84.16 millionOptionable
Reata Pharmaceuticals, Inc. stock logo
RETA
Reata Pharmaceuticals
32138.15 million27.93 millionOptionable
Select Medical Holdings Co. stock logo
SEM
Select Medical
53,800128.54 million104.69 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Encompass Health stock logo

Encompass Health NYSE:EHC

$116.88 +0.47 (+0.40%)
Closing price 05/12/2025 03:59 PM Eastern
Extended Trading
$115.00 -1.88 (-1.60%)
As of 04:41 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.

Pediatrix Medical Group stock logo

Pediatrix Medical Group NYSE:MD

$14.34 -0.19 (-1.30%)
Closing price 05/12/2025 03:59 PM Eastern
Extended Trading
$14.22 -0.12 (-0.84%)
As of 04:25 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals, including pediatric nurse practitioners, echocardiographers, other diagnostic technicians, and exercise physiologists; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians, pediatric gastroenterologists; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Reata Pharmaceuticals stock logo

Reata Pharmaceuticals NASDAQ:RETA

Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney disease (CKD) caused by Alport syndrome, as well as for a form of pulmonary arterial hypertension associated with connective tissue disease; omaveloxolone to treat Friedreich's ataxia; and conduct various form of CKD, such as, type 1 and type 2 diabetic CKD, type 1 and type 2 diabetic CKD, hypertensive CKD, focal segmental glomerulosclerosis, and others. It is also developing RTA 901 for neurological diseases; and bardoxolone for the treatment of autosomal dominant polycystic kidney disease. In addition, the company has a strategic collaboration agreement with Kyowa Kirin Co., Ltd. to develop and commercialize bardoxolone for renal, cardiovascular, diabetes, and various other related metabolic indications in Japan, China, Hong Kong, Macao, South Korea, Taiwan, Thailand, Singapore, the Philippines, Malaysia, Indonesia, Brunei, Vietnam, Laos, Myanmar, and Cambodia; AbbVie Inc. to jointly research, develop, and commercialize all second- and later-generation Nrf2 activators for all indications other than renal, cardiovascular, and metabolic indications. Reata Pharmaceuticals, Inc. was incorporated in 2002 and is headquartered in Plano, Texas.

Select Medical stock logo

Select Medical NYSE:SEM

$15.27 +0.35 (+2.32%)
Closing price 05/12/2025 03:59 PM Eastern
Extended Trading
$15.14 -0.12 (-0.79%)
As of 04:29 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra. The Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. The Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer. The Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services. The Concentra segment operates and provides occupational health centers, telemedicine platforms, onsite clinics, and contract services at employer worksites that deliver occupational health services, consumer health, physical therapy, and preventive care. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.